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The detection of BruceUla bacteremia by subculture does not always correlate with a positive signal in the
BACTEC NR730 nonradiometric system (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md.). The
effect of the inoculum size, pH, sodium polyanetholesulfonate, carbon sources (i-erythritol, sodium pyruvate,
monosodium glutamate, D-glucose, and L-alanine), and urea in the release of CO2 was evaluated by using the
reference strain BruceUla melitensis 16M. In standard NR6 vials with or without blood, inocula 5 to 10 times
larger (at least 265 CFU per vial) than those usually found in the blood of patients with brucellosis were
necessary to produce a positive growth value (GV) in 4 days or less, and similar results were obtained with vials
supplemented with the substrates listed above. GVs were consistently lower in vials with sodium polyaneth-
olesulfonate than in vials without this agent. Vials with no blood inoculated with 265 CFU per vial showed
turbidity 1 day before GVs became positive, proving that the major limiting detection factor was the low level
of release of CO2 and not an inadequate growth medium. In NR6 vials buffered to pH 6.2, GVs became positive
faster and were higher than those in standard vials. NR6 vials at pH 6.2 with 0.3% sodium pyruvate yielded
a positive GV in the first day of bacterial turbidity.
The diagnosis of human brucellosis is based on microbio-
logical and serological laboratory tests. The presence of
antibodies does not always mean an active case of brucello-
sis, and therefore, serological results must be interpreted in
light of clinical and bacteriological data. The unequivocal
proof of an active Brucella infection is the culture, isolation,
and identification of the causative microorganism, and the
blood broth culture under a 10% CO2 atmosphere is the
simplest and most often used procedure (6). However,
conventional blood cultures for Brucella spp. present several
problems. First, unless Castanieda's method (1) is adopted, a
broth culture suspected of containing Brucella spp. must be
streaked out onto a solid medium, and when performed
routinely, this step represents a real risk of infection for
laboratory personnel (12). Moreover, since the majority of
conventional Castafieda blood cultures for Brucella spp. are
positive between days 7 and 21 and 2% are positive after day
27 (23), long incubation periods are necessary before a blood
culture can be rejected as negative for Brucella spp. Several
automated methods for the fast detection of bacteremias
have been described. These methods avoid unnecessary
sampling and streaking out of blood cultures. The semiauto-
matic nonradiometric system for hemocultures, BACTEC
NR730 (Becton Dickinson Diagnostic Instrument Systems,
Sparks, Md.), is one of the most widely used. This system
detects bacterial growth by infrared spectroscopy measure-
ment of the release of CO2. Although the BACTEC NR730
system is more rapid and reliable than other systems (5, 11,
31), it presents problems such as false-negative results or the
delayed detection of bacteremias caused by Neissena, Can-
dida, or Streptococcus spp. (2, 24, 33). Moreover, Serrano et
al. (25) found that protracted periods of incubation are
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necessary to detect Brucella melitensis with the BAClTEC
NR730 system. Several reasons could explain this observa-
tion. First, the bacterial concentration found in individuals
with Brucella bacteremia is usually low. Second, the me-
dium used in BACTEC vials could be unsuitable for Brucella
growth. Finally, because of the peculiarities of Brucella
metabolism (21, 22), the CO2 release could be not enough to
be detectable.
In the work described here, we studied the influence of
these factors for the prompt detection ofBrucella spp. by the
BACT7EC NR730 system using the reference strain B.
melitensis 16M.
MATERUILS AND METHODS
Experimental design. Aerobic BACTEC NR6A (NR6) and
BACTEC NR6AX (NR6AX) vials were used; both were
supplied by the manufacturer (Becton Dickinson-Spain,
Madrid, Spain). The components of the NR6 vial were
tryptic soy broth (2.75%), hemin (0.0005%), vitamin K
(0.00005%), glucose (0.06%), sucrose (0.0835%), sodium poly-
anetholesulfonate (SPS) (0.025%), yeast extract (0.25%), and
pyridoxal HCl (0.001%) in 30 ml of purified water (pH 7.2). The
composition of NR6AX broth was that of NR6 but without
SPS. Various organic substrates and pHs in NR6 vials were
tested individually or in different combinations (see below).
When used, blood was obtained from healthy donors, and
blood was added (3 to 4 ml per vial) immediately after extrac-
tion. The sterility of the blood samples was examined for each
experiment by adding the same volume to noninoculated vials.
The organism used was the virulent strain B. melitensis
16M ATCC 12345 (reference strain of biotype 1). To ensure
the smoothness of the strain, it was inoculated intraperito-
neally into mice, recovered from the spleen 2 weeks later,
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and tested for dissociation (1). The fresh isolate was used to
prepare a stock suspension (3.6 x 107 CFU/ml) in skim milk
that was stored at -70°C. The inocula were prepared by
appropriate dilution of the stock suspension in sterile saline.
For each experiment, the actual size of the inoculum was
measured by spreading triplicate 0.1-ml samples of the
inoculum onto tryptic soy agar plates and incubating the
plates for 4 days at 36°C.
Vials were incubated at 36°C with constant shaking (Or-
bital Shaker 650; Becton Dickinson Diagnostic Instrument
Systems, Towson, Md.), and when turbidity was apparent
(1.0 on the McFarland scale in vials without blood), growth
values (GVs) were recorded with the BACTEC system.
Following the manufacturer's instructions, a GV of .20 or
.35 was considered positive for vials without or with blood,
respectively. All the experiments were performed at least
twice by using 5 to 10 vials per experiment. To counteract
the effects of pH and blood per se on the release of CO2,
uninoculated control vials at different pHs (see below) with
and without blood supplement were included in all the
experiments. Their GVs were subtracted from the ones
obtained in the respective inoculated vials.
Carbon sources. The supplements and the range of final
concentrations were as follows: sodium pyruvate, 3 to 12
mg/ml; monosodium glutamate, 2.5 to 10.0 mg/ml; i-erythri-
tol, 0.05 to 2.00 mg/ml; urea, 2 to 20 mg/ml; D-glucose, 2.5 to
10.0 mg/ml; and L-alanine, 3 to 12 mg/ml. All supplements
were purchased from Sigma Chemical Co. (St. Louis, Mo.).
Working solutions were sterilized by filtration (0.20-,um pore
size; DynaGard-ME; Microgon Inc., Laguna Hills, Calif.)
and were added aseptically to the BACIEC vial. Noninoc-
ulated vials were used to verify the sterilities of the solu-
tions.
pH adjustment. Different proportions of 0.5 M KH2PO4
and 0.5 M Na2HPO4 were added aseptically to the BAClEC
vials to adjust the pH in the range of 6.0 to 7.2 (4). By this
method, the maximum concentration of total phosphorus in
the vials was 0.30% for pH 6.0, which is lower than the
inhibitory concentration for Brucella spp. (0.70% [35]). This
method resulted in a stable pH throughout the incubation
periods, as shown by measurements performed in noninoc-
ulated vials and in inoculated vials taken at different incuba-
tion times and sterilized by autoclaving.
RESULTS
Effect of inoculum size. Figure 1 shows the influence of the
inoculum size on the GV in NR6 vials (no blood). Bacterial
turbidity was apparent on the third day with the highest
inoculum (2,650 CFU per vial) and on the fourth day with the
other inocula. However, with 265 CFU per vial or greater, a
positive GV signal was obtained on the fourth day, while
vials with lower inocula were negative until the sixth day of
incubation. Since smaller inocula are found in patients with
Brucella bacteremia, 15 to 45 CFU per vial (equivalent to a
final concentration of approximately 1 CFU/ml) was used in
subsequent experiments.
Effect of SPS. NR6 and NR6AX vials (with and without
SPS, respectively) inoculated with the same amount of
bacteria showed the same turbidity (1.0 on the McFarland
scale) after 4 days of incubation, and both had a negative
GV. However, NR6AX vials had a positive GV (mean +
standard deviation, 27.3 + 16.3) on the fifth day of incuba-
tion, while NR6 vials were still negative (GV, 10.1 +- 4.9)
(Fig. 2). Similar results were observed when blood supple-
GV
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FIG. 1. Effect of inoculum size on the GV in NR6 vials without
blood. The following inoculum sizes (CFU per vial) were used: 3
(A), 10 (0), 33 (l), 265 (-), and 2,650 (A). The asterisk indicates the
positive GV threshold.
ment was used: 36.8 + 11.9 in NR6AX vials versus 18.2 +
1.7 in NR6 vials on the fifth day of incubation.
Effect of carbon sources in standard vials at pH 7.2. The
addition of any of the carbon substrates to standard NR6
vials did not generate a positive GV in the first day of
bacterial turbidity (fourth day of incubation). A small but
consistent increase in the GV was observed only in the vials
supplemented with 0.6 or 1.2% L-alanine on the sixth day of
incubation (Fig. 3, pH 7.2). The addition of 0.6% sodium
pyruvate also caused a small increase in the GV, although
this did not occur consistently (data not shown).
Effect of pH, L-alanine, and sodium pyruvate. In standard
NR6 vials, the pH changed from 7.2 to 6.9 upon inoculation
and incubation for up to 6 days. When the pH of the
nonsupplemented NR6 broth was adjusted to 6.2 (Fig. 3 and
4), CO2 release was significantly increased, with a positive
GV on the fifth day of incubation (inoculum of 19 CFU per
vial). However, on the fifth day, vials with pHs of greater
than 6.2 still gave a negative GV (Fig. 4). In addition, the
bacterial turbidity in vials at pH 6.2 was apparent 7 h before
bacterial turbidity was apparent in vials at pH 7.2. More-
over, at pH 6.2 both alanine and pyruvate had a marked
effect on the GV. Vials at pH 6.2 supplemented with 0.6%
alanine gave a positive GV on the fourth day of incubation
(Fig. 3), and with 0.6% sodium pyruvate, even higher GVs
were consistently observed (Fig. 4). The addition of this
GV
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FIG. 2. Effect of SPS on the GV of B. melitensis 16M. NR6 vials
(with SPS) and NR6AX vials (without SPS) were inoculated with 16
CFU per vial. The asterisk indicates the positive GV threshold.
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FIG. 3. Effect of pH and L-alanine on the GV. NR6 vials were
supplemented with 0.3 (E), 0.6 (E), or 1.2% (0) L-alanine, and the
pH was adjusted to 6.2 or 7.2. The inoculum used was 42 CFU of B.
melitensis 16M per vial. Standard vials (m) were used as controls.
The asterisk indicates the positive GV threshold.
compound in vials at pH 6.6 increased the GV on the fifth
day of incubation (Fig. 4). Furthermore, with the pyruvate
supplement, turbidity appeared 5 and 12 h before turbidity
appeared in vials without pyruvate at pH 6.2 and in standard
vials, respectively. Similar results were obtained in experi-
ments performed with blood in the vials: a positive GV (70.0
+ 7.8) in vials with 0.6% sodium pyruvate at pH 6.2 on the
fifth day of incubation, when standard vials were still nega-
tive.
DISCUSSION
The BACTEC NR730 is a semiautomatic system that is
based on the detection of the CO2 released during bacterial
growth. It was created for the fast and safe detection of
bacteremia. Our results show that the release of CO2 by B.
melitensis was not high enough to be detected as positive by
the system and that it was clearly preceded by Brucella
growth. This observation is consistent with the low yield of
CO2 per hydrocarbon molecule assimilated reported for
Brucella abortus (10) and explains the delayed detection of
Brucella bacteremia with the BACTEC system compared
with that by conventional subculturing (25).
Several factors can account for that delay: first, the low
concentration of bacteria usually found in patients with
4th day
GV
Brucella bacteremia (1 to 5 CFU/ml [17]) and the compara-
tively long (2.5 to 3.5 h [14, 20]) doubling time of the genus.
In our experiments, only inocula of 265 CFU per vial or
higher generated a positive GV after 4 days of incubation. A
similar influence of the size of the inoculum has been
reported by Zimmerman et al. (34). Second, in contrast to
most aerobic bacteria that channel glucose into the Krebs
cycle through the Embden-Meyerhof-Parnas and Entner-
Doudoroff pathways, both radiorespirometric (21) and enzy-
matic (22) studies support a model for Brucella spp. in which
the bulk of glucose catabolism is via the hexose monophos-
phate pathway. Thus, substrates that bypass this pathway
and that are fed directly into the Krebs cycle could enhance
CO2 release, a hypothesis supported by our observation that
both alanine and pyruvate accelerated B. melitensis 16M
growth and increased CO2 release. The other substrates
tested could not be incorporated directly into the Krebs
cycle (erythritol [26, 27]), or their oxidation (glutamate)
could be affected by the cell's permeability (32). Although B.
melitensis often presents a strong urease activity, the addi-
tion of this substrate did not increase the release of CO2.
Finally, since the solubility of CO2 in the broth is affected by
the pH, the release of CO2 into the vial's atmosphere should
be lessened in bacteria that, like Brucella spp., do not acidify
the growth medium. We found that reduction of the pH from
7.2 to 6.2 was enough to generate a positive GV signal in the
first day of bacterial growth. Indeed, the combination of
sodium pyruvate and low pH produced a further increase in
CO2 release, as observed before by several investigators (8,
21).
The modifications introduced into the NR6 broth should
not affect the aerobic bacteria that have classical glucose
metabolic pathways and that are found in blood cultures. In
fact, supplementation of the NR6 vials with 0.6% sodium
pyruvate at pH 6.2 generated a higher GV than that in
standard vials (100 CFU per vial) of clinical isolates of
Staphylococcus aureus, Staphylococcus epidermidis, Sal-
monella enteritidis, Salmonella typhimurium, Citrobacter
freundii, Proteus mirabilis, Streptococcus faecalis, Kleb-
siella pneumoniae, and Acinetobacter calcoaceticus (30).
Although the addition of SPS increases the growth of most
bacteria in hemocultures, it has been reported that it has an
adverse effect on the growth of Neisseria meningitidis,
Neisseria gonorrhoeae, Peptostreptococcus anaerobius,
Streptobacillus monilifonnis, and Gardnerella vaginalis (7,
9, 13, 18, 24, 28). The same negative effect was observed for
5th day
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FIG. 4. Effect of pH and sodium pyruvate on the GV. NR6 vials were supplemented with 0.6% sodium pyruvate, and the pH was adjusted
to 6.2, 6.6, or 7.2. The inoculum used was 19 CFU of B. melitensis 16M per vial. Standard vials were used as controls. The asterisk indicates
the positive GV threshold.
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B. melitensis 16M, since GVs were higher in vials without
SPS (NR6AX) than in vials with SPS (NR6). This adverse
effect of SPS could be due to the permeability of Brucella
outer membranes to hydrophobic substances (16), an inter-
pretation in agreement with the fact that the outer mem-
branes of N. meningitidis and N. gonorrhoeae, the other
gram-negative bacteria affected by SPS, are also permeable
to such substances (15). However, the anticoagulant, anti-
phagocytic, anticomplementary, and aminoglycoside-inacti-
vating activities of SPS (3, 19, 29) make it an essential
component of most commercial blood culture media (19).
Therefore, a substance with properties similar to those of SPS
but that is nontoxic should be included in broths designed for
hemocultures suspected of containing Brucella spp.
In summary, although further studies are necessary to
assess the practical value of the proposed modifications, the
use of pyruvate, a moderately acidic pH, and an agent
different from SPS are factors that should be taken into
account in the improvement of growth media designed to
detect Brucella spp. by CO2 release.
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